secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0000950170-24-013823
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney grants supplemental stock option to Chief Legal Officer Todd Girolamo
-------------------------------------------------------------------------------

- Option for 234,742 Class A ordinary shares at FMV on March 1, 2024 grant date.
- Vesting: 50% on March 1, 2025; remainder in equal monthly installments over 12 months.
- Award approved Feb 6, 2024 under 2022 Incentive Equity Plan for retention purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/0000950170-24-013823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024013823/prok-20240206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-013823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer